vs
Side-by-side financial comparison of Outdoor Holding Co (POWW) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $13.4M, roughly 1.5× Outdoor Holding Co). Outdoor Holding Co runs the higher net margin — 16.7% vs -84.4%, a 101.0% gap on every dollar of revenue. On growth, Outdoor Holding Co posted the faster year-over-year revenue change (-54.1% vs -65.2%). Outdoor Holding Co produced more free cash flow last quarter ($5.0M vs $-39.7M).
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
POWW vs TRDA — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.4M | $20.6M |
| Net Profit | $2.2M | $-17.3M |
| Gross Margin | 87.1% | — |
| Operating Margin | 14.7% | -106.0% |
| Net Margin | 16.7% | -84.4% |
| Revenue YoY | -54.1% | -65.2% |
| Net Profit YoY | 108.5% | -173.8% |
| EPS (diluted) | $0.01 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.4M | — | ||
| Q3 25 | $12.0M | — | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | $12.6M | $20.6M | ||
| Q4 24 | $12.5M | $37.4M | ||
| Q3 24 | $12.0M | $19.6M | ||
| Q2 24 | $12.3M | $94.7M | ||
| Q1 24 | $-50.7M | $59.1M |
| Q4 25 | $2.2M | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $-6.5M | — | ||
| Q1 25 | $-77.5M | $-17.3M | ||
| Q4 24 | $-26.1M | $1.1M | ||
| Q3 24 | $-12.4M | $-14.0M | ||
| Q2 24 | $-14.8M | $55.0M | ||
| Q1 24 | $-5.2M | $23.5M |
| Q4 25 | 87.1% | — | ||
| Q3 25 | 87.1% | — | ||
| Q2 25 | 87.2% | — | ||
| Q1 25 | 87.5% | — | ||
| Q4 24 | 87.4% | — | ||
| Q3 24 | 86.9% | — | ||
| Q2 24 | 85.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 14.7% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | -50.7% | — | ||
| Q1 25 | -213.6% | -106.0% | ||
| Q4 24 | -163.8% | -15.7% | ||
| Q3 24 | -50.3% | -110.7% | ||
| Q2 24 | -50.8% | 56.4% | ||
| Q1 24 | — | 35.7% |
| Q4 25 | 16.7% | — | ||
| Q3 25 | 11.7% | — | ||
| Q2 25 | -54.5% | — | ||
| Q1 25 | -614.5% | -84.4% | ||
| Q4 24 | -208.7% | 3.0% | ||
| Q3 24 | -103.7% | -71.7% | ||
| Q2 24 | -120.2% | 58.1% | ||
| Q1 24 | 10.3% | 39.7% |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.67 | $-0.42 | ||
| Q4 24 | $-0.23 | $-0.20 | ||
| Q3 24 | $-0.11 | $-0.35 | ||
| Q2 24 | $-0.13 | $1.55 | ||
| Q1 24 | $-0.05 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.9M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $237.3M | $417.3M |
| Total Assets | $271.7M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $69.9M | — | ||
| Q3 25 | $65.7M | — | ||
| Q2 25 | $63.4M | — | ||
| Q1 25 | $30.2M | $67.8M | ||
| Q4 24 | $31.9M | $101.2M | ||
| Q3 24 | $33.5M | $78.0M | ||
| Q2 24 | $50.8M | $185.3M | ||
| Q1 24 | $55.6M | $68.4M |
| Q4 25 | $237.3M | — | ||
| Q3 25 | $235.4M | — | ||
| Q2 25 | $222.5M | — | ||
| Q1 25 | $222.0M | $417.3M | ||
| Q4 24 | $299.6M | $428.7M | ||
| Q3 24 | $325.6M | $422.4M | ||
| Q2 24 | $342.5M | $429.9M | ||
| Q1 24 | $358.0M | $269.4M |
| Q4 25 | $271.7M | — | ||
| Q3 25 | $270.3M | — | ||
| Q2 25 | $269.5M | — | ||
| Q1 25 | $297.3M | $486.5M | ||
| Q4 24 | $355.4M | $526.3M | ||
| Q3 24 | $368.9M | $554.6M | ||
| Q2 24 | $398.6M | $582.0M | ||
| Q1 24 | $403.0M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $-38.5M |
| Free Cash FlowOCF − Capex | $5.0M | $-39.7M |
| FCF MarginFCF / Revenue | 37.6% | -192.9% |
| Capex IntensityCapex / Revenue | 4.8% | 5.6% |
| Cash ConversionOCF / Net Profit | 2.55× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | — | ||
| Q3 25 | $3.2M | — | ||
| Q2 25 | $-6.7M | — | ||
| Q1 25 | $-1.5M | $-38.5M | ||
| Q4 24 | $1.3M | $-31.6M | ||
| Q3 24 | $-9.3M | $-24.3M | ||
| Q2 24 | $-547.5K | $39.8M | ||
| Q1 24 | $4.3M | $-25.5M |
| Q4 25 | $5.0M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-2.3M | $-39.7M | ||
| Q4 24 | $720.3K | $-32.2M | ||
| Q3 24 | $-10.6M | $-24.9M | ||
| Q2 24 | $-1.3M | $38.8M | ||
| Q1 24 | $1.4M | $-26.4M |
| Q4 25 | 37.6% | — | ||
| Q3 25 | 21.0% | — | ||
| Q2 25 | -63.8% | — | ||
| Q1 25 | -18.6% | -192.9% | ||
| Q4 24 | 5.8% | -86.2% | ||
| Q3 24 | -88.3% | -127.3% | ||
| Q2 24 | -11.0% | 41.0% | ||
| Q1 24 | -2.8% | -44.6% |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 6.5% | 5.6% | ||
| Q4 24 | 4.4% | 1.7% | ||
| Q3 24 | 10.4% | 3.3% | ||
| Q2 24 | 6.5% | 1.1% | ||
| Q1 24 | -5.7% | 1.4% |
| Q4 25 | 2.55× | — | ||
| Q3 25 | 2.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
